Skip to main content
"Existing PAH therapies do not cure the disease. But as researchers begin to understand the underlying causes of PAH, it opens the door to testing new treatments, of which apabetalone is only one. As evidence shows that PAH is a complex disease with epigenetic dysregulations, it may be that a combination of treatments that can target many contributing disease pathways is what will bring us closer to a cure."

Read more here.